N. Shanks et al., Alterations in hypothalamic-pituitary-adrenal function correlated with theonset of murine SLE in MRL plus / plus and lpr/lpr mice, BRAIN BEH, 13(4), 1999, pp. 348-360
Systemic lupus erythematosus (SLE) is a spontaneously occurring, chronic au
toimmune disease that can manifest neuropsychiatric abnormalities. The path
ways mediating these central changes are not known; however, neuroendocrine
alterations associated with inflammation may play a role. Predisposition t
o and progression of autoimmune disease has been associated with altered hy
pothalamic-pituitary-adrenal (BPA) function and inflammation has been repor
ted to alter hypothalamic regulation of MPA responses. We investigated whet
her disease progression in a murine model of systemic lupus erythematosus (
MRL +/+. MRL lpr/lpr) resulted in altered expression of HPA regulatory pept
ides at the level of the hypothalamus and how these alterations related to
circulating levels of corticosterone, corticosterone binding globulin, and
autoantibody titers. We report that as MRL +/+ and MRL lpr/lpr mice age and
circulating levels of autoantibodies increase, there is a decrease in hypo
thalamic CRH mRNA expression and finally an increase in AVP mRNA expression
. We also report that associated with increased autoantibody levels, diseas
e progression, and altered hypothalamic peptide expression there is an incr
ease in circulating levels of corticosterone and a trend for levels of cort
icosterone binding globulin to decrease. Our data complement previous obser
vations of altered peptidergic regulation of the PIPA axis and increased HP
A activity during chronic inflammation in exogenously induced rodent models
of chronic inflammation and indicate that similar processes may occur in s
pontaneous murine models of SLE. (C) 1999 Academic Press.